NLRP3 and major depressive disorder: In summary, the release of inflammatory cytokines mediated by TLR4/NLRP3 inflammasome signaling pathway-induced immunoinflammation may represent a common pathogenic mechanism underlying the development of gastrointestinal diseases and depression.